Small tidbits and Sparks of wisdom

.

Researchers have identified three possible brain-based categories, known as biotypes, each associated with different patterns of brain structure and behavior.

The study, published in JAMA Psychiatry in February 2026, offers a new perspective on Attention-Deficit/Hyperactivity Disorder (ADHD).

1. Type One: ADHD With Emotional Dysregulation

This is the most complex of the three groups, combining problems with attention, hyperactivity, impulsivity, and emotional regulation.

Common characteristics:

– Difficulty concentrating and completing tasks.
– Strong emotional reactions and frustration.
– Mood swings and emotional outbursts.
– Impulsive decisions and poor self-control.
– Difficulty calming down after becoming upset.

Brain findings:

Researchers identified differences involving the medial prefrontal cortex and globus pallidus, brain regions associated with emotional regulation, decision-making, and impulse control.

Treatment implications:

These individuals may benefit from treatment that addresses both ADHD symptoms and emotional regulation, including appropriate medication and behavioral therapy.

2. Type Two: Predominantly Hyperactive and Impulsive ADHD

This group is characterized primarily by excessive activity and difficulty controlling impulses.

Common characteristics:

– Physical restlessness and difficulty sitting still.
– Excessive talking and interrupting others.
– Impatience and difficulty waiting.
– Acting without considering consequences.
– Difficulty controlling immediate reactions.

Brain findings:

Researchers observed differences in circuits connecting the anterior cingulate cortex and globus pallidus, which help regulate behavior and suppress inappropriate responses.

Treatment implications:

Treatment may emphasize impulse control, behavioral regulation, and managing excessive activity.

3. Type Three: Predominantly Inattentive ADHD

This group is characterized by difficulty maintaining concentration, organizing information, and completing tasks, often without obvious hyperactivity.

Common characteristics:

– Forgetfulness and frequent daydreaming.
– Difficulty following instructions.
– Poor organization and time management.
– Losing personal belongings.
– Starting projects without finishing them.
– Becoming distracted by unrelated thoughts or activities.

Brain findings:

Researchers identified differences involving the superior frontal gyrus, a brain region associated with working memory, concentration, and sustained attention.

Treatment implications:

Treatment may focus on improving attention, organization, task completion, and executive functioning.

Because these individuals may be quiet rather than disruptive, their difficulties can sometimes go unnoticed, particularly during childhood.

4. What Makes This Discovery Important?

Doctors have long recognized that ADHD symptoms vary considerably between individuals.

Some patients are highly active and impulsive. Others struggle primarily with concentration. Still others experience significant emotional difficulties.

The important development is that researchers have identified biological patterns associated with these differences.

The study examined brain-imaging data from children with ADHD and compared neurological characteristics across different symptom profiles.

Researchers also investigated associations between these brain patterns and neurotransmitter systems, including dopamine and serotonin.

However, these findings do not establish that each subtype has a specific chemical deficiency or that a particular medication is best suited to each group.

5. Could This Change ADHD Treatment?

Currently, ADHD treatment often involves evaluating symptoms and adjusting medications according to individual responses.

Two patients with similar diagnoses may respond differently to the same medication.

The new research raises the possibility that future treatment could become more individualized, with doctors using neurological information to help select appropriate therapies.

Nevertheless, these three biotypes remain research classifications. They are not yet established diagnostic categories, and brain scans are not currently recommended as a routine method of selecting ADHD medication.

6. Conclusion

ADHD should not necessarily be understood as a single, uniform neurological condition.

The research suggests that individuals diagnosed with ADHD may have different underlying brain characteristics, even when their outward symptoms overlap.

The distinction between emotional dysregulation, hyperactivity and impulsivity, and inattention may eventually help researchers develop more precise diagnostic methods and treatments.

The central finding is that similar behavioral symptoms do not necessarily reflect identical underlying brain patterns.

Further research is needed before these discoveries can be translated into routine clinical practice.

—

Sources and Further Reading

1. JAMA Psychiatry (2026) — Original research on ADHD brain biotypes.
   https://jamanetwork.com/journals/jamapsychiatry

2. National Geographic (October 26, 2026) — There might be 3 different types of ADHD, new brain study suggests.
   https://on.natgeo.com/BRWA102626

3. Medical Xpress — Research coverage of distinct ADHD brain biotypes.
   https://medicalxpress.com

4. Healthline — Discussion of ADHD subtypes and potential treatment implications.
   https://www.healthline.com

Medical note: These findings are preliminary and do not replace established ADHD diagnostic criteria or individualized medical evaluation.